Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study)

To achieve global hepatitis elimination by 2030, it is critical to prevent the mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Since 2009, the WHO has recommended administering hepatitis B vaccine to all neonates within 24 h of birth to prevent MTCT. However, many countries in sub-Sa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccines (Basel)
Main Authors: Tall, Haoua, Adam, Pierrick, Tiendrebeogo, Abdoul Salam Eric, Vincent, Jeanne Perpétue, Schaeffer, Laura, von Platen, Cassandre, Fernandes-Pellerin, Sandrine, Sawadogo, François, Bokoum, Alkadri, Bouda, Ghislain, Ouattara, Seydou, Ouédraogo, Issa, Herrant, Magali, Boucheron, Pauline, Sawadogo, Appolinaire, Betsem, Edouard, Essoh, Alima, Kabore, Lassané, Ouattara, Amariane, Méda, Nicolas, Hien, Hervé, Gosset, Andréa, Giles-Vernick, Tamara, Boyer, Sylvie, Kania, Dramane, Vray, Muriel, Shimakawa, Yusuke
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8227098/
https://ncbi.nlm.nih.gov/pubmed/34206058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060583
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados